Circulating levels of soluble P-selectin in patients in the early and recent phases of myocardial infarction

Chang Gung Medical Journal

Volumn 28, Issue 9, 2005, Pages 613-620

  Liu, Wen Hao ^a   Yang, Cheng Hsu ^a   Yeh, Kuo Ho ^a   Chang, Hsueh Wen ^b   Chen, Yen Hsun ^a   Chen, Shyh Ming ^a   Cheng, Cheng I ^a   Chen, Chien Jen ^a   Yu, Teng Hung ^a   Hung, Wei Chin ^a   Hang, Chi Ling ^a   Wu, Chiung Jen ^a   Yip, Hon Kan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Early or recent myocardial infarction; Soluble P selectin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CLOPIDOGREL; PADGEM PROTEIN; THROMBOCYTE ANTIBODY; TIROFIBAN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RISK; STABLE ANGINA PECTORIS;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; P-SELECTIN; TIME FACTORS;

EID: 27744552399     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. van der Wall AC, Becker AE, van der Loos CM, Das PK. Site of intimal rapture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
2. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992;359:848-51.
3. Wagner DD. The Weibel-Palade body: the storage granule for von Willebrand factor and p-selectin. Thromb Haemost 1993;70:1-5.
4. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet α-glanule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989;84:92-9.
5. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginberg MH, Furie B. A platelet alpha-granule membrane protein that is associated with the plasma membrane after activation: characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest 1986;78:130-7.
6. Carlos TM, Harlan JM. Leukocyte-endothelial cell adhesion molecules. Blood 1998;84:2069-101.
7. Hsu SL, Herman CL, Furie BC, Augus D, Furie B. A platelet membrane protein expressed during platelet activation and secretion: studies using a monoclonal antibody specific for thrombin-activated platelets. J Biol Chem 1984;259:9121-6.
8. Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA. 1995;92:7450-4.
9. Gamble JR, Skinner MP, Berndt MC, Vadas MA. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP 140. Science 1990;249:414-7.
10. Shimomura H, Ogawa H, Arai H, Arai H, Moriyama Y, Takazoe K, Hirai N, Kaikita K, Hirashima O, Misumi K, Soejima H, Nishiyama K, Yasue H. Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction. Am J Cardiol 1998;81:397-400.
11. Gurbel PA, O'Connor CM, Dalesandro MR, Serebruany VL. Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy. Am J Cardiol 2001;87:774-7.
12. Cheng MC, Chang HW, Juang SS, Yip HK, Wu CJ. Increased plasma levels of soluble P-selectin in rheumatic mitral stenosis. Chest 2004;126:54-8.
13. Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003;101:2661-6.
14. Yip HK, Chen SS, Liu JS, Chang HW, Kao YF, Lan MY, Chang YY, Lai SL, Chen WH, Chen MC. Serial changes in platelet activation in patients after ischemic stroke: role of pharmacodynamic modulation. Stroke 2004;35:1683-7.
15. Davi G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci GG, Ciabattoni G, Patrono C. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo: evidence derived from the study of peripheral arterial disease. Circulation 1997;96:69-75.
16. van Kooten F, Ciabattoni G, Koudstaal PJ, Dipple DWJ, Patrono C. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. Stroke 1999;30:546-9.
17. Kabbani SS, Watkins MW, Ashikaga T, Terrien EF, Holoch PA, Sobel BE, Schneider DJ. Platelet reactivity characterized prospectively a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 2001;104:181-6.
18. Berger G, Hartwell DW, Wangner DD. P-selectin and platelet clearance. Blood 1998;92:4446-52.
19. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by p-selectin on adherent platelets. Nature 1992;359:848-51.
20. Jaakkola K, Jalkanen S, Kaunismaki K, Vanttinen E, Saukko P, Alanen K, Kallajoki M, Voipio-Pulkki LM, Salmi M. Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. J Am Coll Cardiol 2000;36:122-9.
21. Ross R. The pathogenesis of atherosclerosis: a perspective for 1990s. Nature 1993;362:801-9.
22. Faruqi RM, Di Corleto PE. Mechanisms of monocyte recruitment and accumulation. Br Heart J 1993;69:S19-S29.
23. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
24. Kawabata K, Nagake Y, Shikata K, Fukuda S, Nakazono H, Takahashi M, Ichikawa H, Makino H. Soluble P-selectin is released from activated platelets in vivo during hemodialysis. Nephron 1998;78:148-55.